Immunopathogenesis of IgAN and the Evolving Treatment Landscape: A Focus on the B-Cell Pathway

<p>Discover how emerging B-cell-targeted therapies are transforming the treatment landscape and outcomes for patients with IgA nephropathy (IgAN).</p> <p>Credit available for this activity expires: 9/18/26<br /> Earn Credit / Learning Objectives & Disclosures: <a href= "https://www.medscape.org/viewarticle/1002833" target="_blank" rel= "noopener">https://www.medscape.org/viewarticle/1002833?ecd=bdc_podcast_libsyn_mscpedu</a></p>